Dive Into Relatiant’s Dash Innovative Solutions For Enduring Challenges In Healthcare

 

 

Navigating the labyrinthine world of healthcare can be daunting, with the challenges in healthcare presenting both patients and providers with numerous hurdles. However, imagine a world where these challenges are significantly reduced; where seeing your doctor isn’t an exercise in patience, making payments is straightforward, and the concept of a ‘digital front door’ for healthcare isn’t a far-off dream but a reality.

This is the world that Dash, a healthcare platform, aims to create. Focusing on breaking down the barriers of confusion and complexity, Dash is all set to revolutionize healthcare accessibility. The future is indeed bright for Dash with its potential to scale, transform patient access, and bring unprecedented changes.

David Dyke, Chief Product Officer, Jeff Gartland, CEO  and Emily Tyson, Chief Operating Officer, all at Relatient are at the helm of these pathbreaking developments, tackling the enduring challenges in healthcare head-on. They discuss these development and more on this episode of Dash Talk.

Recent Episodes

In this episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims welcomes Syl Trepanier, DNP, RN, Chief Nursing Officer for Providence Health and member of the TruMerit Board of Trustees. With responsibility for representing more than 36,000 nurses across a multi-state health system, Syl shares his personal journey from caregiving as…

The accelerator model is undergoing a transformation, and at the center of this change is HealthTech Arkansas, a powerful program that’s redefining the traditional approach by guaranteeing clinical pilots for healthcare startups. As the healthcare system faces a mounting burden from chronic disease (cardiovascular-related costs alone are projected to reach a staggering $1.8 trillion…

Michael Rothman explores the complexities of sepsis identification and management, highlighting the challenges posed by varying definitions and clinical pathways. He discusses the ineffectiveness of current sepsis screening protocols, which often yield high false-positive rates and fail to reduce mortality meaningfully. The episode concludes by questioning the focus on sepsis-specific initiatives and suggesting that more…